Wilms Tumor 1 Expression and Pre-emptive Immunotherapy in Patients with Acute Myeloid Leukemia Undergoing an Allogeneic Hemopoietic Stem Cell Transplantation

Abstract Minimal residual disease (MRD) was monitored by Wilms tumor 1 ( WT1 ) expression in 207 patients with acute myeloid leukemia (AML) after an allogeneic hemopoietic stem cell transplantation (HSCT) as a trigger to initiate pre-emptive immunotherapy (IT) with cyclosporin discontinuation and/or...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Biology of blood and marrow transplantation 2016-07, Vol.22 (7), p.1242-1246
Hauptverfasser:	Di Grazia, Carmen, Pozzi, Sarah, Geroldi, Simona, Grasso, Raffaella, Miglino, Maurizio, Colombo, Nicoletta, Tedone, Elisabetta, Luchetti, Silvia, Lamparelli, Teresa, Gualandi, Francesca, Ibatici, Adalberto, Bregante, Stefania, Van Lint, Maria Teresa, Raiola, Anna Maria, Dominietto, Alida, Varaldo, Riccardo, Galaverna, Federica, Ghiso, Anna, Sica, Simona, Bacigalupo, Andrea
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute myeloid leukemia Adolescent Adult Aged Allogeneic hemopoietic stem cell transplantation Bone Marrow Cells - metabolism Female Hematology, Oncology and Palliative Medicine Hematopoietic Stem Cell Transplantation - methods Humans Immunotherapy - methods Immunotherapy, Adoptive Leukemia, Myeloid, Acute - mortality Leukemia, Myeloid, Acute - therapy Lymphocyte Transfusion Male Middle Aged Premedication - methods Transplantation, Homologous Wilms tumor 1 (WT1) WT1 Proteins - analysis Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!